Merck KGaA, Darmstadt, Germany, announced a collaboration and licensing agreement with Domain Therapeutics, Strasbourg, France, to explore the potential of adenosine inhibition in the development of novel immuno-oncology agents.
Elizabeth Comen originally set out to write a book about the wellness industry, but ended up writing a different book altogether.
